Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week 
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed 
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand 
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act 
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute 
How Marco Pharma International Preserves German Homeopathic Traditions in America 
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports 
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility 
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App 
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year 
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates 
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves 
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit 
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks 
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes 
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks 
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains 
TAMPA, Fla., Feb. 16, 2018 -- United Consortium Ltd. (OTC PINK:UCSO), an acquisition and development Company focused on creating shareholder value by identifying and monetizing opportunities in Block Chain, Technology, Digital Media and the Emerging Cannabis Space, today announced that it has completed the process to upgrade its stock listing on OTC Markets to “Current Information”.
UCL Chairman and Chief Executive Officer Scott Gallagher stated, “While the process of removing the stop sign took longer than expected, we’re pleased to become a reporting Company on OTC Markets as we enter 2018.” Gallagher continued, “We can now focus our energy on the pending launch of our PHR Block Chain on March 15th. We’ll be hosting an investor conference call after the market closes on March 1st to discuss the launch of our personal health records block chain as well as provide additional information regarding the forward moving plans for our wholly owned subsidiary Block Chain, Inc.”
About United Consortium Ltd. (UCL)
UCL is an acquisition and development Company focused on creating shareholder value by identifying and monetizing opportunities in Technology, Internet, New Media and the Emerging Cannabis Space. The Company is headquartered in Tampa, Florida. The most current information about the Company can be found on OTCMarkets.com or by visiting the Company's website at www.UCLVentures.com.
Forward-Looking Statements
This release contains forward-looking statements that relate to future events or United Consortium Ltd. (UCL's) future performance or financial condition. Any statements that are not statements of historical fact, such as the statements above and including statements containing the words "plans," "anticipates," "expects" and similar expressions, should also be considered to be forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as result of a number of factors, including those described from time to time in United Consortium Ltd.’s filings with the Securities and Exchange Commission, OTC Markets or statement on the Companies websites. United Consortium Ltd. And all of its subsidiary companies undertakes no duty to update any forward-looking statements made herein.
Contact Information
For additional information contact:
Scott Gallagher
727-417-7807
